Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV006459729 | SCV007343255 | uncertain significance | not specified | 2026-01-02 | criteria provided, single submitter | clinical testing | |
| Revvity Omics, |
RCV003139996 | SCV003824288 | uncertain significance | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | |
| Fulgent Genetics, |
RCV002483845 | SCV002789428 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-08-18 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000643323 | SCV000765010 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-11-21 | criteria provided, single submitter | clinical testing |